CRNA — Circio Holding ASA Share Price
0.000.00%
Last trade - 00:00- NOK48.47m
- NOK47.58m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NOKm | 0.62 | n/a | 10 | 0.12 | n/a | 100 | 144 | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Directors
- Patrick Vink CHM (58)
- Erik Digman Wiklund CEO
- Oystein Soug CFO (47)
- Jon Eriksen COO
- Antti Vuolanto EVP
- Victor Levitsky CSO
- Anne Aksnes VPR
- Tina Madsen VPR
- Peter Skorpil VBD
- Nikolaj Knudtzon DHR
- Magnus Jaderberg OTH
- Ola Melin OTH
- Lone Ottesen OTH
- Eva-Lotta Allan DRC (62)
- Bente-Lill Bjerkelund Romoren DRC
- Robert Burns DRC
- Johan Christenson DRC (64)
- Diane Mellett DRC (54)
- Per Samuelsson DRC (60)
- Catherine Wheeler DRC
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 9th, 2010
- Public Since
- June 16th, 2014
- No. of Shareholders
- 5,726
- No. of Employees
- 10
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Oslo Stock Exchange
- Shares in Issue
- 70,150,662
- Address
- Vollsveien 19, LYSAKER, 1366
- Web
- https://www.circio.com/en/
- Phone
- +47 21398810
- Auditors
- RSM Norge AS
Upcoming Events for CRNA
Circio Holding ASA Annual Shareholders Meeting
Half Year 2025 Circio Holding ASA Earnings Release
Similar to CRNA
Arcticzymes Technologies ASA
Oslo Stock Exchange
Bergenbio ASA
Oslo Stock Exchange
Exact Therapeutics AS
Oslo Stock Exchange
Lifecare ASA
Oslo Stock Exchange
Lytix Biopharma AS
Oslo Stock Exchange
FAQ
What is the Circio Holding ASA share price?
As of Today at 19:57 UTC, shares in Circio Holding ASA are trading at NOK0.69. This share price information is delayed by 15 minutes.
How has the Circio Holding ASA share price performed this year?
Shares in Circio Holding ASA last closed at NOK0.69 and the price had moved by -68.53% over the past 365 days. In terms of relative price strength the Circio Holding ASA share price has underperformed the FTSE Global All Cap Index by -69.31% over the past year.
What are the analyst and broker recommendations for Circio Holding ASA?
The overall consensus recommendation for Circio Holding ASA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Circio Holding ASA dividend yield?
Circio Holding ASA does not currently pay a dividend.
Does Circio Holding ASA pay a dividend?
Circio Holding ASA does not currently pay a dividend.
When does Circio Holding ASA next pay dividends?
Circio Holding ASA does not currently pay a dividend.
How do I buy Circio Holding ASA shares?
To buy shares in Circio Holding ASA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Circio Holding ASA?
As of the previous close price of NOK0.69, shares in Circio Holding ASA had a market capitalisation of NOK48.47m.
Where are Circio Holding ASA shares listed?
Here are the trading details for Circio Holding ASA:
- Country of listing: Norway
- Exchange: OSL
- Ticker Symbol: CRNA
What kind of share is Circio Holding ASA?
Based on an overall assessment of its quality, value and momentum Circio Holding ASA is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Circio Holding ASA share price forecast for 2025?
The analyst consensus target price for shares in Circio Holding ASA is NOK3.00. That is 334.15% above the last closing price of NOK0.69.
Analysts covering Circio Holding ASA currently have a consensus Earnings Per Share (EPS) forecast of -NOK3.73 for the next financial year.
Find out moreWhat is the trend in the Circio Holding ASA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Circio Holding ASA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -52.69%.
As of the last closing price of NOK0.69, shares in Circio Holding ASA were trading -28.18% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Circio Holding ASA PE Ratio?
The Circio Holding ASA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NOK0.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Circio Holding ASA?
Circio Holding ASA's management team is headed by:
- Patrick Vink - CHM
- Erik Digman Wiklund - CEO
- Oystein Soug - CFO
- Jon Eriksen - COO
- Antti Vuolanto - EVP
- Victor Levitsky - CSO
- Anne Aksnes - VPR
- Tina Madsen - VPR
- Peter Skorpil - VBD
- Nikolaj Knudtzon - DHR
- Magnus Jaderberg - OTH
- Ola Melin - OTH
- Lone Ottesen - OTH
- Eva-Lotta Allan - DRC
- Bente-Lill Bjerkelund Romoren - DRC
- Robert Burns - DRC
- Johan Christenson - DRC
- Diane Mellett - DRC
- Per Samuelsson - DRC
- Catherine Wheeler - DRC